InsiderClue
Stocks · Health care · Biological Products, (No Diagnostic Substances)

REPLIGEN CORP

RGEN Clue Score52
United States Fiscal year ends December CIK 0000730272
$173.88 +6.13% Close, 9 Oct 2026
Alert on the numbers Alert on insider trades
Price $173.88 −31.46% Close, 9 Oct 2026

Closing prices at the end of each trading day, from 12 Oct 2016. Not a live quote. Adjusted for share splits, so the line has no step at a split; dividends are not added back. P/E and P/FCF are the market value over the last full fiscal year's net income or free cash flow, as public on each day, so they step once a year when the annual report comes out. A hatched band marks a stretch with none: a year of net loss, or of cash burnt.

Revenue and profit

What the business sells, and what is left of it. Point at a year for the detail.
RevenueOperating incomeNet income
Fiscal year 2016Revenue104.5Operating income16.0Net income11.7EPS, diluted0.34Fiscal year 2017Revenue141.2 +35.1%Operating income14.0Net income28.4 +142.7%EPS, diluted0.72Fiscal year 2018Revenue194.0 +37.4%Operating income26.0Net income16.6 −41.4%EPS, diluted0.37Fiscal year 2019Revenue270.2 +39.3%Operating income36.1Net income21.4 +28.8%EPS, diluted0.44Fiscal year 2020Revenue366.3 +35.5%Operating income69.8Net income59.9 +179.9%EPS, diluted1.11Fiscal year 2021Revenue670.5 +83.1%Operating income167.2Net income128.3 +114.1%EPS, diluted2.24Fiscal year 2022Revenue801.5 +19.5%Operating income224.7Net income186.0 +45.0%EPS, diluted3.24Fiscal year 2023Revenue632.4 −21.1%Operating income47.7Net income35.6 −80.9%EPS, diluted0.63Fiscal year 2024Revenue634.4 +0.3%Operating income−35.1Net income−25.5 −171.7%EPS, diluted−0.46Fiscal year 2025Revenue738.3 +16.4%Operating income55.2Net income48.9EPS, diluted0.86
FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Revenue 104.5 141.2 194.0 270.2 366.3 670.5 801.5 632.4 634.4 738.3
Growth +35.1% +37.4% +39.3% +35.5% +83.1% +19.5% −21.1% +0.3% +16.4%
Operating income 16.0 14.0 26.0 36.1 69.8 167.2 224.7 47.7 −35.1 55.2
Net income 11.7 28.4 16.6 21.4 59.9 128.3 186.0 35.6 −25.5 48.9
Growth +142.7% −41.4% +28.8% +179.9% +114.1% +45.0% −80.9% −171.7%
EPS, diluted 0.34 0.72 0.37 0.44 1.11 2.24 3.24 0.63 −0.46 0.86

Margins

How much of each dollar of revenue it keeps. Point at a year for the detail.
Operating marginNet margin
Fiscal year 2016Operating margin15.3%Net margin11.2%Free cash flow margin3.1%Fiscal year 2017Operating margin9.9%Net margin20.1%Free cash flow margin8.5%Fiscal year 2018Operating margin13.4%Net margin8.6%Free cash flow margin11.4%Fiscal year 2019Operating margin13.4%Net margin7.9%Free cash flow margin18.0%Fiscal year 2020Operating margin19.1%Net margin16.4%Free cash flow margin11.0%Fiscal year 2021Operating margin24.9%Net margin19.1%Free cash flow margin7.7%Fiscal year 2022Operating margin28.0%Net margin23.2%Free cash flow margin10.9%Fiscal year 2023Operating margin7.5%Net margin5.6%Free cash flow margin12.3%Fiscal year 2024Operating margin−5.5%Net margin−4.0%Free cash flow margin23.6%Fiscal year 2025Operating margin7.5%Net margin6.6%Free cash flow margin12.7%
FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Operating margin 15.3% 9.9% 13.4% 13.4% 19.1% 24.9% 28.0% 7.5% −5.5% 7.5%
Net margin 11.2% 20.1% 8.6% 7.9% 16.4% 19.1% 23.2% 5.6% −4.0% 6.6%
Free cash flow margin 3.1% 8.5% 11.4% 18.0% 11.0% 7.7% 10.9% 12.3% 23.6% 12.7%

Cash flow

The cash the business makes, what it reinvests, and what it hands back. Point at a year for the detail.
Operating cash flowCapital expenditureFree cash flow
Fiscal year 2016Operating cash flow7.5Capital expenditure−4.3Free cash flow3.2Fiscal year 2017Operating cash flow17.5Capital expenditure−5.5Free cash flow12.0 +275.4%Fiscal year 2018Operating cash flow32.8Capital expenditure−10.6Free cash flow22.1 +84.5%Fiscal year 2019Operating cash flow67.2Capital expenditure−18.5Free cash flow48.7 +120.1%Fiscal year 2020Operating cash flow62.6Capital expenditure−22.5Free cash flow40.2 −17.5%Fiscal year 2021Operating cash flow119.0Capital expenditure−67.1Free cash flow51.9 +29.3%Buybacks0.0Fiscal year 2022Operating cash flow172.1Capital expenditure−84.8Free cash flow87.2 +68.0%Buybacks0.0Fiscal year 2023Operating cash flow113.9Capital expenditure−36.2Free cash flow77.7 −10.9%Buybacks−14.4Fiscal year 2024Operating cash flow175.4Capital expenditure−25.7Free cash flow149.7 +92.7%Buybacks0.0Fiscal year 2025Operating cash flow117.4Capital expenditure−23.5Free cash flow93.9 −37.3%Buybacks0.0
FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Operating cash flow 7.5 17.5 32.8 67.2 62.6 119.0 172.1 113.9 175.4 117.4
Capital expenditure −4.3 −5.5 −10.6 −18.5 −22.5 −67.1 −84.8 −36.2 −25.7 −23.5
Free cash flow 3.2 12.0 22.1 48.7 40.2 51.9 87.2 77.7 149.7 93.9
Growth +275.4% +84.5% +120.1% −17.5% +29.3% +68.0% −10.9% +92.7% −37.3%
Buybacks n/a n/a n/a n/a n/a 0.0 0.0 −14.4 0.0 0.0

Balance sheet

What it holds against what it owes, at each year end. Point at a year for the detail.
CashTotal debt
Fiscal year 2016Cash122.2Shareholders’ equity168.8Fiscal year 2017Cash173.8Shareholders’ equity591.5Fiscal year 2018Cash193.8Shareholders’ equity615.6Fiscal year 2019Cash528.4Shareholders’ equity1,059.8Fiscal year 2020Cash717.3Shareholders’ equity1,529.2Fiscal year 2021Cash603.8Shareholders’ equity1,750.1Fiscal year 2022Cash523.5Shareholders’ equity1,910.7Fiscal year 2023Cash751.3Shareholders’ equity1,964.8Fiscal year 2024Cash757.4Total debt525.6Net cash (debt)231.8Shareholders’ equity1,972.7Debt to equity0.27Fiscal year 2025Cash566.0Total debt542.2Net cash (debt)23.8Shareholders’ equity2,106.1Debt to equity0.26
FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Cash 122.2 173.8 193.8 528.4 717.3 603.8 523.5 751.3 757.4 566.0
Total debt n/a n/a n/a n/a n/a n/a n/a n/a 525.6 542.2
Net cash (debt) n/a n/a n/a n/a n/a n/a n/a n/a 231.8 23.8
Shareholders’ equity 168.8 591.5 615.6 1,059.8 1,529.2 1,750.1 1,910.7 1,964.8 1,972.7 2,106.1
Debt to equity n/a n/a n/a n/a n/a n/a n/a n/a 0.27 0.26

In millions of USD, except per-share figures and ratios. Fiscal years, as last filed with the SEC.

Financial statements FY2025 · 10-K

Cash flow

In millions of USD, except per-share figures; shares in millions. Fiscal years ending December, each column as last filed with the SEC.
Click a line to chart it
Fiscal year FY2016 31 Dec 2016 FY2017† 31 Dec 2017 FY2018 31 Dec 2018 FY2019 31 Dec 2019 FY2020† 31 Dec 2020 FY2021 31 Dec 2021 FY2022 31 Dec 2022 FY2023 31 Dec 2023 FY2024 31 Dec 2024 FY2025 31 Dec 2025
Operations
7.5 17.5 32.8 67.2 62.6 119.0 172.1 113.9 175.4 117.4
Growth +132.0% +87.8% +105.1% −6.8% +90.0% +44.6% −33.8% +54.0% −33.1%
Investment
−4.3 −5.5 −10.6 −18.5 −22.5 −67.1 −84.8 −36.2 −25.7 −23.5
calc 3.2 12.0 22.1 48.7 40.2 51.9 87.2 77.7 149.7 93.9
Growth +275.4% +84.5% +120.1% −17.5% +29.3% +68.0% −10.9% +92.7% −37.3%
calc 93.73 0.31 0.49 0.99 745.38 906.80 1,518.56 1,378.15 2,676.53 1,660.12
−49.2 −98.7 −14.0 −205.3 −201.4 −221.2 −233.2 −123.3 −86.4 −298.5
Financing
112.1 129.9 3.4 484.9 305.9 1.0 −13.3 249.0 −82.9 −15.2
n/a n/a n/a n/a n/a 0.0 0.0 −14.4 0.0 0.0

† The diluted share count jumps at 2017 and 2020, so per-share figures either side of that column are not comparable. Usually a split, but the break lands on the restatement boundary rather than on the split date, because every column is that period’s latest filing.

Lines marked calc are worked out here from filed figures; point at one for how. Capital expenditure, dividends and buybacks are shown as money out, so negative.